Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of Zoom calls and deadlines has returned, along with a spot of snow in our neck of the world. Before continuing, we apologize for the late arrival this morning, but we encountered a bit of a problem here on the Pharmalot campus that required our attention. Now, though, we are focused on the matters at hand. So here are a few tidbits to start the day. We hope all goes well and you conquer the world. …
AstraZeneca (AZN) chief executive Pascal Soriot promised to churn out more Covid-19 vaccines, at a lower price, than any of his rivals, The Wall Street Journal writes. Now, a production problem at a single factory in Belgium has delayed tens of millions of doses destined for Europe, endangering the continent’s already-slow inoculation drive and representing the greatest threat so far to his extraordinary pledge last year to vaccinate the world — and do so for no profit. After disclosing the European problem, the drug maker now says it has been troubleshooting similar production issues in recent weeks as far away as the U.S. and Australia.
About the Author Reprints
